Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?
Suter
T M
TM
Meier
B
B
D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D015994:Incidence; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D011322:Primary Prevention; D011379:Prognosis; D018570:Risk Assessment
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic